Abstract

Protein kinase C (PKC)-alpha phosphorylation of recombinant NG2 cytoplasmic domain and phorbol ester-induced PKC-dependent phosphorylation of full-length NG2 expressed in U251 cells are both blocked by mutation of Thr(2256), identifying this residue as a primary phosphorylation site. In untreated U251/NG2 cells, NG2 is present along with ezrin and alpha(3)beta(1) integrin in apical cell surface protrusions. Phorbol ester treatment causes redistribution of all three components to lamellipodia, accompanied by increased cell motility. U251 cells expressing NG2 with a valine substitution at position 2256 are resistant to phorbol ester treatment: NG2 remains in membrane protrusions and cell motility is unchanged. In contrast, NG2 with a glutamic acid substitution at position 2256 redistributes to lamellipodia even without phorbol ester treatment, rendering transfected U251 cells spontaneously motile. PKC-alpha-mediated NG2 phosphorylation at Thr(2256) is therefore a key step for initiating cell polarization and motility.

Highlights

  • Transmembrane proteoglycans such as CD44 and syndecans make important contributions to communication between the exterior and interior of the cell [1, 2]

  • U251 cells expressing NG2 with a valine substitution at position 2256 are resistant to phorbol ester treatment: NG2 remains in membrane protrusions and cell motility is unchanged

  • Phosphorylation of NG2 at Thr2256 is accompanied by redistribution of the proteoglycan on the cell surface, by polarization of the cell and several key molecular components, and by significant increases in cell motility

Read more

Summary

Introduction

Transmembrane proteoglycans such as CD44 and syndecans make important contributions to communication between the exterior and interior of the cell [1, 2]. To determine possible utilization of these residues as phosphorylation sites, phosphoamino acid analysis was performed on NG2 immunoprecipitated from transfected U251 cells (U251/NG2) metabolically 32Pi-labeled in the presence of the serine/threonine kinase inhibitor calyculin A (30 nM).

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call